| Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management M Harbord, R Eliakim, D Bettenworth, K Karmiris, K Katsanos, U Kopylov, ... Journal of Crohn's and Colitis 11 (7), 769-784, 2017 | 1298* | 2017 |
| European evidence based consensus for endoscopy in inflammatory bowel disease V Annese, M Daperno, MD Rutter, A Amiot, P Bossuyt, J East, M Ferrante, ... Journal of Crohn's and Colitis 7 (12), 982-1018, 2013 | 911 | 2013 |
| Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction S Sebastian, S Johnston, T Geoghegan, W Torreggiani, M Buckley Official journal of the American College of Gastroenterology| ACG 99 (10 …, 2004 | 886 | 2004 |
| 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations P Gionchetti, A Dignass, S Danese, FJ Magro Dias, G Rogler, PL Lakatos, ... Journal of Crohn's and Colitis 11 (2), 135-149, 2017 | 771 | 2017 |
| Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines J Panes, Y Bouhnik, W Reinisch, J Stoker, SA Taylor, DC Baumgart, ... Journal of Crohn's and Colitis 7 (7), 556-585, 2013 | 733 | 2013 |
| East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort J Burisch, N Pedersen, S Čuković-Čavka, M Brinar, I Kaimakliotis, ... Gut 63 (4), 588-597, 2014 | 563 | 2014 |
| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 554 | 2019 |
| The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease CJ Van der Woude, S Ardizzone, MB Bengtson, G Fiorino, G Fraser, ... Journal of Crohn's and Colitis 9 (2), 107-124, 2015 | 495 | 2015 |
| HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 303 | 2020 |
| British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott, RM Beattie, ... Gut 69 (6), 984-990, 2020 | 289 | 2020 |
| Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD NA Kennedy, S Lin, JR Goodhand, N Chanchlani, B Hamilton, ... Gut 70 (10), 1884-1893, 2021 | 256 | 2021 |
| Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study J Burisch, G Kiudelis, L Kupcinskas, HAL Kievit, KW Andersen, ... Gut 68 (3), 423-433, 2019 | 233 | 2019 |
| Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial JG Williams, MF Alam, L Alrubaiy, I Arnott, C Clement, D Cohen, ... The lancet Gastroenterology & hepatology 1 (1), 15-24, 2016 | 223 | 2016 |
| European Crohn’s and Colitis Organisation topical review on treatment withdrawal [‘exit strategies’] in inflammatory bowel disease G Doherty, KH Katsanos, J Burisch, M Allez, K Papamichael, A Stallmach, ... Journal of Crohn's and Colitis 12 (1), 17-31, 2018 | 192 | 2018 |
| Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab NA Kennedy, JR Goodhand, C Bewshea, R Nice, D Chee, S Lin, ... Gut 70 (5), 865-875, 2021 | 174 | 2021 |
| European Crohn’s and Colitis Organisation topical review on IBD in the elderly A Sturm, C Maaser, M Mendall, D Karagiannis, P Karatzas, N Ipenburg, ... Journal of Crohn's and Colitis 11 (3), 263-273, 2017 | 168 | 2017 |
| Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis A Jena, S Mishra, P Deepak, P Kumar-M, A Sharma, YI Patel, ... Autoimmunity reviews 21 (1), 102927, 2022 | 160 | 2022 |
| Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I) S Sebastian, HV Hernández, P Myrelid, R Kariv, E Tsianos, M Toruner, ... Journal of Crohn's and Colitis 8 (1), 5-18, 2014 | 156 | 2014 |
| The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric … S Sebastian, H Jenkins, S McCartney, T Ahmad, I Arnott, N Croft, ... Journal of Crohn's and Colitis 6 (8), 830-844, 2012 | 143 | 2012 |
| Current therapeutic options for gastric antral vascular ectasia S Sebastian, CA O'morain, MJM Buckley Alimentary pharmacology & therapeutics 18 (2), 157-165, 2003 | 142 | 2003 |
Christian Philipp SelingerLeeds Teaching Hospitals NHS TrustVerified email at leedsth.nhs.uk
